Cargando…
Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran
BACKGROUND: Pharmaceuticals have made an important contribution to global reductions in morbidity and mortality. To help save lives and improve health, it is important to be sure about equity to access to drugs, drug efficacy, quality and safety, and rational use of drugs, which are standardized Nat...
Autores principales: | Nikfar, Shekoufeh, Kebriaeezadeh, Abbas, Majdzadeh, Reza, Abdollahi, Mohammad |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1145184/ https://www.ncbi.nlm.nih.gov/pubmed/15885139 http://dx.doi.org/10.1186/1472-698X-5-5 |
Ejemplares similares
-
A model for developing a decision support system to simulate national drug policy indicators
por: Abdollahiasl, Akbar, et al.
Publicado: (2011) -
A system dynamics model for national drug policy
por: Abdollahiasl, Akbar, et al.
Publicado: (2014) -
Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries
por: Kebriaeezadeh, Abbas, et al.
Publicado: (2013) -
Direct and indirect cost of managing Alzheimer’s disease in the Islamic Republic of Iran
por: Aajami, Zahra, et al.
Publicado: (2019) -
Commercialization of biopharmaceutical knowledge in Iran; challenges and solutions
por: Nassiri-Koopaei, Nasser, et al.
Publicado: (2014)